development of the chromatographic medium for the affinity isolation of the recombinant hifn-β1b based on immobilized single-chain antibodies
Clicks: 203
ID: 203770
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
203 views
23 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #14 of 23 articles by views in medicines
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Aim. The development of a laboratory method for the production of immunoaffinity chromatography medium for the purification of the recombinant human IFN-β1b. Methods. A gene of the chimeric protein ScFvbINF-CBD was constructed using the DNA sequences encoding ScFv specific to hIFN-β1b and the cellulose-binding domain (CBD) of Clostridium thermocellum. The developed chimeric protein was expressed in Escherichia coli cells. The target protein was obtained in soluble, functionally active form by its renaturation from the bacterial inclusion bodies in vitro. The ScFvbINF-CBD was immobilized on a chitin carrier. Results. The introduction of CBD by gene engineering techniques enabled the oriented non-covalent immobilization of ScFvbINF-CBD on chromatographic matrix. The developed immunoaffinity medium allowed isolating the rhIFN-β1b from the complex mixture, after its renaturation from the inclusion bodies, with more than 89 % purity. Conclusion. The designed immunoaffinity medium provides isolating the rhIFN-β1b from the complex protein mixtures.
| Reference Key |
o.2015biopolymersdevelopment
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Pokholenko Ia. O.;Gorbatiuk O. B.;Okunev O. V.;Irodov D. M.;Degtiarova M. I.;Palivoda O. G.;Kordium V. A. |
| Journal | medicines |
| Year | 2015 |
| DOI |
10.7124/bc.0008EC
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.